Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles R McQuade

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|February 25, 2009
Therapeutic use of the phosphate binder lanthanum carbonateAmy Barton Pai, Todd A Conner, Charles R McQuade
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 2008
Elevated serum creatinine levels associated with fenofibrate therapyCharles R McQuade, Jennifer Griego, Joe Anderson, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 14, 2011
Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucroseAmy Barton Pai, Todd Conner, Charles R McQuade, et al.
American Journal of Nephrology|July 1, 2006
Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucroseAmy Barton Pai, Manjunath P Pai, Joseph Depczynski, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
Correlation between the renal quality of life profile and short form-36 in a United States hemodialysis populationAlex V Boyd, Charles R McQuade, Todd Conner, et al.
Pharmacotherapy|February 24, 2007
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysisAmy Barton Pai, Alex V Boyd, Charles R McQuade, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Metabolism & Toxicology|February 25, 2009
Therapeutic use of the phosphate binder lanthanum carbonateAmy Barton Pai, Todd A Conner, Charles R McQuade
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 15, 2008
Elevated serum creatinine levels associated with fenofibrate therapyCharles R McQuade, Jennifer Griego, Joe Anderson, et al.
Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|January 14, 2011
Non-transferrin bound iron, cytokine activation and intracellular reactive oxygen species generation in hemodialysis patients receiving intravenous iron dextran or iron sucroseAmy Barton Pai, Todd Conner, Charles R McQuade, et al.
American Journal of Nephrology|July 1, 2006
Non-transferrin-bound iron is associated with enhanced Staphylococcus aureus growth in hemodialysis patients receiving intravenous iron sucroseAmy Barton Pai, Manjunath P Pai, Joseph Depczynski, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|February 13, 2009
Correlation between the renal quality of life profile and short form-36 in a United States hemodialysis populationAlex V Boyd, Charles R McQuade, Todd Conner, et al.
Pharmacotherapy|February 24, 2007
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysisAmy Barton Pai, Alex V Boyd, Charles R McQuade, et al.
Pageof 1